A multimodal deep learning prognostic model based on histopathology outperforms current gold standards for identifying patients with endometrial cancer with different outcomes, in multiple external validation cohorts.
- Sarah Volinsky-Fremond
- Nanda Horeweg
- Tjalling Bosse
